Literature DB >> 33499382

Rind from Purple Mangosteen (Garcinia mangostana) Attenuates Diet-Induced Physiological and Metabolic Changes in Obese Rats.

Oliver D John1, Peter Mouatt2, Sunil K Panchal1, Lindsay Brown1,3.   

Abstract

The pulp of the purple mangosteen, Garcinia mangostana, is a popular tropical fruit but the rind containing xanthones such as α-mangostin together with procyanidins and anthocyanidins is usually discarded as waste. However, this rind has been used in South-East Asia for diarrhoea, dysentery, skin infections and wounds. As xanthones have reported anti-inflammatory and antioxidant responses, this study has determined the bioactive compounds and evaluated the effects of G. mangostana rind on physiological, metabolic, liver and cardiovascular parameters in rats with diet-induced metabolic syndrome. Rats fed a diet with increased simple sugars and saturated fats developed obesity, hypertension, increased left ventricular stiffness, dyslipidaemia and fatty liver. Administration of G. mangostana rind as 5% of the food to rats with diet-induced metabolic syndrome gave a dose of 168 mg/kg/day α-mangostin, 355 mg/kg/day procyanidins, 3.9 mg/kg/day anthocyanins and 11.8 mg/kg/day hydroxycitric acid for 8 weeks which reduced body weight and attenuated physiological and metabolic changes in rats including decreased abdominal fat deposition, decreased abdominal circumference and whole-body fat mass, improved liver structure and function and improved cardiovascular parameters such as systolic blood pressure, left ventricular stiffness and endothelial function. These responses were associated with decreased infiltration of inflammatory cells, decreased deposition of collagen in both heart and liver and decreased mean adipocyte size in retroperitoneal adipose tissues. We conclude that, in rats with diet-induced metabolic syndrome, chronic intake of G. mangostana rind decreased infiltration of inflammatory cells which decreased physiological, metabolic, liver and cardiovascular symptoms.

Entities:  

Keywords:  Garcinia mangostana rind; cardiovascular disease; metabolic syndrome; rats; α-mangostin

Year:  2021        PMID: 33499382      PMCID: PMC7912346          DOI: 10.3390/nu13020319

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  52 in total

Review 1.  Evaluation of the safety and efficacy of hydroxycitric acid or Garcinia cambogia extracts in humans.

Authors:  Fabiola Márquez; Nancy Babio; Mònica Bulló; J Salas-Salvadó
Journal:  Crit Rev Food Sci Nutr       Date:  2012       Impact factor: 11.176

Review 2.  Proanthocyanidins: A comprehensive review.

Authors:  Abdur Rauf; Muhammad Imran; Tareq Abu-Izneid; Seema Patel; Xiandao Pan; Saima Naz; Ana Sanches Silva; Farhan Saeed; Hafiz Ansar Rasul Suleria
Journal:  Biomed Pharmacother       Date:  2019-05-27       Impact factor: 6.529

Review 3.  New insights into the anti-obesity activity of xanthones from Garcinia mangostana.

Authors:  Qian-Yu Liu; Yi-Tao Wang; Li-Gen Lin
Journal:  Food Funct       Date:  2015-02       Impact factor: 5.396

4.  Garcinia mangostana pericarp extract protects against oxidative stress and cardiovascular remodeling via suppression of p47phox and iNOS in nitric oxide deficient rats.

Authors:  Pattanapong Boonprom; Orachorn Boonla; Kanokporn Chayaburakul; Jariya Umka Welbat; Patchareewan Pannangpetch; Upa Kukongviriyapan; Veerapol Kukongviriyapan; Poungrat Pakdeechote; Parichat Prachaney
Journal:  Ann Anat       Date:  2017-04-26       Impact factor: 2.698

Review 5.  Metabolic syndrome update.

Authors:  Scott M Grundy
Journal:  Trends Cardiovasc Med       Date:  2015-10-31       Impact factor: 6.677

6.  α-Mangostin induces apoptosis and suppresses differentiation of 3T3-L1 cells via inhibiting fatty acid synthase.

Authors:  Xiaofang Quan; Yi Wang; Xiaofeng Ma; Yan Liang; Weixi Tian; Qingyun Ma; Hezhong Jiang; Youxing Zhao
Journal:  PLoS One       Date:  2012-03-09       Impact factor: 3.240

7.  α-Mangostin ameliorates hepatic steatosis and insulin resistance by inhibition C-C chemokine receptor 2.

Authors:  Hong Min Kim; You Mi Kim; Ji Hye Huh; Eun Soo Lee; Mi Hye Kwon; Bo Ra Lee; Hyun-Jeong Ko; Choon Hee Chung
Journal:  PLoS One       Date:  2017-06-09       Impact factor: 3.240

8.  Saturated fatty acids induce development of both metabolic syndrome and osteoarthritis in rats.

Authors:  Sunderajhan Sekar; Siti Raihanah Shafie; Indira Prasadam; Ross Crawford; Sunil K Panchal; Lindsay Brown; Yin Xiao
Journal:  Sci Rep       Date:  2017-04-18       Impact factor: 4.379

Review 9.  Biological activities and bioavailability of mangosteen xanthones: a critical review of the current evidence.

Authors:  Fabiola Gutierrez-Orozco; Mark L Failla
Journal:  Nutrients       Date:  2013-08-13       Impact factor: 5.717

10.  Achacha (Garcinia humilis) Rind Improves Cardiovascular Function in Rats with Diet-Induced Metabolic Syndrome.

Authors:  Oliver D John; Stephen Wanyonyi; Peter Mouatt; Sunil K Panchal; Lindsay Brown
Journal:  Nutrients       Date:  2018-10-04       Impact factor: 5.717

View more
  4 in total

Review 1.  Anthocyanins in Chronic Diseases: The Power of Purple.

Authors:  Sunil K Panchal; Oliver D John; Michael L Mathai; Lindsay Brown
Journal:  Nutrients       Date:  2022-05-23       Impact factor: 6.706

2.  Anti-Obesity Effects of Matoa (Pometia pinnata) Fruit Peel Powder in High-Fat Diet-Fed Rats.

Authors:  Toshikazu Suzuki; Mayumi Nagata; Natsuko Kagawa; Shiori Takano; Jun Nomura
Journal:  Molecules       Date:  2021-11-07       Impact factor: 4.411

3.  Inhibitory Effects against Alpha-Amylase of an Enriched Polyphenol Extract from Pericarp of Mangosteen (Garcinia mangostana).

Authors:  Xiaofang Li; Haoze Chen; Yan Jia; Jinming Peng; Chunmei Li
Journal:  Foods       Date:  2022-03-29

Review 4.  The metabolic and molecular mechanisms of α‑mangostin in cardiometabolic disorders (Review).

Authors:  Oliver Dean John; Annals Tatenda Mushunje; Noumie Surugau; Rhanye Mac Guad
Journal:  Int J Mol Med       Date:  2022-07-29       Impact factor: 5.314

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.